- Cancer Genetics (NASDAQ:CGIX) is up 8% premarket on light volume in reaction to its announcement that it has engaged H.C. Wainwright to assist it in exploring shareholder value-boosting strategic alternatives, including a possible sale or merger.
Source: Seeking Alpha